NCT02877290

Brief Summary

In this study, 20 hypercapnic COPD patients will perform two constant workrate endurance cycle tests. One test will be while using non-invasive Ventilation (NIV) support, one without in a randomized cross-over design. The aim is to measure, whether NIV is able to change peripheral and respiratory muscle oxygenation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2016

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

August 19, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 24, 2016

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2017

Completed
Last Updated

November 8, 2017

Status Verified

November 1, 2017

Enrollment Period

1.2 years

First QC Date

August 19, 2016

Last Update Submit

November 7, 2017

Conditions

Keywords

COPDNIRSNIVExercise

Outcome Measures

Primary Outcomes (1)

  • cycle endurance time

    time patient ist able to cycle at 60% of his peak work rate

    maximum 20 minutes

Secondary Outcomes (8)

  • Borg scale of dyspnoea

    30 minutes

  • Borg scale of leg fatigue

    30 minutes

  • Oxygen saturation

    30 minutes

  • Heart rate

    30 minutes

  • Arterial blood pressure

    30 minutes

  • +3 more secondary outcomes

Study Arms (2)

cycling test first with NIV, then without NIV

EXPERIMENTAL

patients in this arm will perform their first constant work rate test while using NIV and the second constant work rate test without NIV

Device: non-invasive ventilation (NIV)

cycling test first without NIV, then with NIV

EXPERIMENTAL

patients in this arm will perform their first constant work rate test without NIV and the second constant work rate test with NIV

Device: non-invasive ventilation (NIV)

Interventions

cycling test first with NIV, then without NIVcycling test first without NIV, then with NIV

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Chronic obstructive pulmonary disease GOLD (Global initiative for chronic obstructive lung disease) stage IV
  • Hypercapnia: pCO2\>50mmHg (at rest or in exercise)
  • written consent

You may not qualify if:

  • orthopaedic comorbidities that do not allow a cycle endurance test
  • acute exacerbation of COPD
  • Cardiac insufficiency, acute coronary syndrome

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Schoen Klinik BGL

Schoenau Am Königssee, Bavaria, 83471, Germany

Location

Related Publications (1)

  • Gloeckl R, Andrianopoulos V, Stegemann A, Oversohl J, Schneeberger T, Schoenheit-Kenn U, Hitzl W, Dreher M, Koczulla AR, Kenn K. High-pressure non-invasive ventilation during exercise in COPD patients with chronic hypercapnic respiratory failure: A randomized, controlled, cross-over trial. Respirology. 2019 Mar;24(3):254-261. doi: 10.1111/resp.13399. Epub 2018 Sep 21.

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveHypercapniaMotor Activity

Interventions

Noninvasive Ventilation

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms, RespiratorySigns and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Respiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Officials

  • Klaus Kenn, Prof. Dr.

    Schoen Klinik BGL

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr. Klaus Kenn

Study Record Dates

First Submitted

August 19, 2016

First Posted

August 24, 2016

Study Start

August 1, 2016

Primary Completion

October 1, 2017

Study Completion

October 1, 2017

Last Updated

November 8, 2017

Record last verified: 2017-11

Data Sharing

IPD Sharing
Will not share

Locations